{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:54:27Z","timestamp":1789782867786,"version":"4.0.1"},"reference-count":131,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Endotheliopathy, according to the \u201ctwo-activation theory of the endothelium\u201d, can be triggered by the activated complement system in critical illnesses, such as sepsis and polytrauma, leading to two distinctly different molecular dysfunctions: (1) the activation of the inflammatory pathway due to the release of inflammatory cytokines, such as interleukin 6 and tumor necrosis factor-\u03b1, and (2) the activation of the microthrombotic pathway due to the exocytosis of hemostatic factors, such as ultra-large von Willebrand factor (ULVWF) multimers and FVIII. The former promotes inflammation, including inflammatory organ syndrome (e.g., myocarditis and encephalitis) and multisystem inflammatory syndrome (e.g., cytokine storm), and the latter provokes endotheliopathy-associated vascular microthrombotic disease (VMTD), orchestrating thrombotic thrombocytopenic purpura (TTP)-like syndrome in arterial endotheliopathy, and immune thrombocytopenic purpura (ITP)-like syndrome in venous endotheliopathy, as well as multiorgan dysfunction syndrome (MODS). Because the endothelium is widely distributed in the entire vascular system, the phenotype manifestations of endotheliopathy are variable depending on the extent and location of the endothelial injury, the cause of the underlying pathology, as well as the genetic factor of the individual. To date, because the terms of many human diseases have been defined based on pathological changes in the organ and\/or physiological dysfunction, endotheliopathy has not been denoted as a disease entity. In addition to inflammation, endotheliopathy is characterized by the increased activity of FVIII, overexpressed ULVWF\/VWF antigen, and insufficient ADAMTS13 activity, which activates the ULVWF path of hemostasis, leading to consumptive thrombocytopenia and microthrombosis. Endothelial molecular pathogenesis produces the complex syndromes of inflammation, VMTD, and autoimmunity, provoking various endotheliopathic syndromes. The novel conceptual discovery of in vivo hemostasis has opened the door to the understanding of the pathogeneses of many endotheliopathy-associated human diseases. Reviewed are the hemostatic mechanisms, pathogenesis, and diagnostic criteria of endotheliopathy, and identified are some of the endotheliopathic syndromes that are encountered in clinical medicine.<\/jats:p>","DOI":"10.3390\/medicina58091311","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:28:55Z","timestamp":1663648135000},"page":"1311","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Molecular Pathogenesis of Endotheliopathy and Endotheliopathic Syndromes, Leading to Inflammation and Microthrombosis, and Various Hemostatic Clinical Phenotypes Based on \u201cTwo-Activation Theory of the Endothelium\u201d and \u201cTwo-Path Unifying Theory\u201d of Hemostasis"],"prefix":"10.3390","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9401-7684","authenticated-orcid":false,"given":"Jae C.","family":"Chang","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California Irvine School of Medicine, Irvine, CA 92868, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement proteins C5b-9 induce secretion of high molecular weight mul-timers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface","volume":"264","author":"Hattori","year":"1989","journal-title":"J. Biol. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.RES.0000216071.87981.16","article-title":"Differential Regulation of Endothelial Cell Activation by Complement and Interleukin 1\u03b1","volume":"98","author":"Brunn","year":"2006","journal-title":"Circ. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.imbio.2011.07.028","article-title":"Complement-mediated injury and protection of endothelium: Lessons from atypical haemolytic uraemic syndrome","volume":"217","author":"Kerr","year":"2012","journal-title":"Immunobiology"},{"key":"ref_4","first-page":"2","article-title":"Thrombocytopenia in critically ill patients due to vascular microthrombotic disease: Pathogenesis based on \u201ctwo activation theory of the endothelium\u201d","volume":"2","author":"Chang","year":"2017","journal-title":"Vasc. Dis. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12959-018-0174-4","article-title":"TTP-like syndrome: Novel concept and molecular pathogenesis of endotheliopathy-associated vascular micro-thrombotic disease","volume":"16","author":"Chang","year":"2018","journal-title":"Thromb. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12959-019-0198-4","article-title":"Sepsis and septic shock: Endothelial molecular pathogenesis associated with vascular microthrombotic disease","volume":"17","author":"Chang","year":"2019","journal-title":"Thromb. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1076029619887437","DOI":"10.1177\/1076029619887437","article-title":"Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis","volume":"25","author":"Chang","year":"2019","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12959-020-00231-0","article-title":"Disseminated intravascular coagulation: New identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis","volume":"18","author":"Chang","year":"2020","journal-title":"Thromb. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21767\/2471-9668.100029","article-title":"Pathogenesis of Ebola Viral Haemorrhagic Fever: TTP-like Syndrome Associated with Hepatic Coagulopathy based on \u201cTwo Activation Theory of the Endothelium\u201d","volume":"3","author":"Chang","year":"2017","journal-title":"J. Prev. Infect. Control"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/VHRM.S299357","article-title":"COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on \u201cTwo-Path Unifying Theory\u201d of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy","volume":"17","author":"Chang","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/MBC.0000000000000765","article-title":"Hemostasis based on a novel \u2018two-path unifying theory\u2019 and classification of hemostatic disorders","volume":"29","author":"Chang","year":"2018","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MBC.0000000000000769","article-title":"Thrombogenesis and thrombotic disorders based on \u201ctwo-path unifying theory of hemostasis: Philosophical, physiological and phenotypical interpretation","volume":"29","author":"Chang","year":"2018","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chang, J.C., and Hawley, H.B. (2021). Vaccine-Associated Thrombocytopenia and Thrombosis: Venous Endotheliopathy Leading to Venous Combined Micro-Macrothrombosis. Medicina, 57.","DOI":"10.3390\/medicina57111163"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Chang, J.C. (2022). Pathogenesis of Two Faces of DVT: New Identity of Venous Thromboembolism as Combined Micro-Macrothrombosis via Unifying Mechanism Based on \u201cTwo-Path Unifying Theory\u201d of Hemostasis and \u201cTwo-Activation Theory of the Endothelium\u201d. Life, 12.","DOI":"10.3390\/life12020220"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.maturitas.2003.10.015","article-title":"Crosstalk between inflammation and thrombosis","volume":"47","author":"Esmon","year":"2004","journal-title":"Maturitas"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2174\/138161212799504731","article-title":"Inflammation-induced thrombosis: Mechanisms, disease associations and management","volume":"18","author":"Aksu","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00109-014-1148-z","article-title":"Extracellular histones in tissue injury and inflammation","volume":"92","author":"Allam","year":"2014","journal-title":"J. Mol. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/blood-2018-11-886267","article-title":"Challenging the concept of immunothrombosis","volume":"133","author":"Palankar","year":"2019","journal-title":"Blood"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/MBC.0000000000000727","article-title":"Disseminated intravascular coagulation (DIC): Is it fact or fancy?","volume":"29","author":"Chang","year":"2018","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Turner, N.A., and Moake, J. (2013). Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059372"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1053\/j.ackd.2020.01.002","article-title":"Complement-Mediated Disorders in Pregnancy","volume":"27","author":"Vijayan","year":"2020","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2014-1099","article-title":"Role of Complement and Complement Regulatory Proteins in the Complications of Diabetes","volume":"36","author":"Ghosh","year":"2015","journal-title":"Endocr. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ajpath.2020.02.006","article-title":"Complement Membrane Attack Complex: New Roles, Mechanisms of Action, and Therapeutic Targets","volume":"190","author":"Xie","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1084\/jem.185.4.745","article-title":"Mapping the Active Site of CD59","volume":"185","author":"Yu","year":"1997","journal-title":"J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/CIRCRESAHA.108.191361","article-title":"Complement Regulator CD59 Protects Against Atherosclerosis by Restricting the Formation of Complement Membrane Attack Complex","volume":"104","author":"Wu","year":"2009","journal-title":"Circ. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1159\/000083843","article-title":"How a damaged blood vessel wall contibutes to thrombosis and hypertension","volume":"33","author":"Blann","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.thromres.2020.06.026","article-title":"A comprehensive assessment of the coagulation profile in critically ill COVID-19 patients","volume":"194","author":"Adam","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0041-1727282","article-title":"Increased VWF and Decreased ADAMTS-13 in COVID-19: Creating a Milieu for (Micro) Thrombosis","volume":"47","author":"Favaloro","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2008.07323.x","article-title":"Virchow and his triad: A question of attribution","volume":"143","author":"Bagot","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1538-7836.2007.02361.x","article-title":"Formation of platelet strings and microthrombi in the presence of ADAMTS-13 inhibitor does not require P-selectin or beta3 integrin","volume":"5","author":"Chauhan","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12185-009-0476-1","article-title":"Pathophysiology of thrombotic thrombocytopenic purpura","volume":"91","author":"Tsai","year":"2010","journal-title":"Int. J. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3324\/haematol.10262","article-title":"Acquired ADAMTS-13 deficiency in pediatric patients with severe sepsis","volume":"92","author":"Nguyen","year":"2007","journal-title":"Haematologica"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Karim, F., Adil, S.N., Afaq, B., and Haq, A.U. (2013). Deficiency of ADAMTS-13 in pediatric patients with severe sepsis and impact on in-hospital mortality. BMC Pediatr., 13.","DOI":"10.1186\/1471-2431-13-44"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/SHK.0b013e3182908ea7","article-title":"Ratio of von Willebrand Factor Propeptide to ADAMTS13 Is Associated with Severity of Sepsis","volume":"39","author":"Fukushima","year":"2013","journal-title":"Shock"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5482\/HAMO-14-12-0081","article-title":"Interaction of von Willebrand factor with platelets and the vessel wall","volume":"35","author":"Mendolicchio","year":"2015","journal-title":"H\u00e4mostaseologie"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e002765","DOI":"10.1161\/CIRCIMAGING.114.002765","article-title":"Molecular Imaging of Platelet\u2013Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis","volume":"8","author":"Shim","year":"2015","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.beha.2008.12.007","article-title":"The coagulopathy of acute promyelocytic leukaemia revisited","volume":"22","author":"Stein","year":"2009","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1076029620913634","DOI":"10.1177\/1076029620913634","article-title":"Stroke Classification: Critical Role of Unusually Large von Willebrand Factor Multimers and Tissue Factor on Clinical Phenotypes Based on Novel \u201cTwo-Path Unifying Theory\u201d of Hemostasis","volume":"26","author":"Chang","year":"2020","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjh.14482","article-title":"How do we approach thrombocytopenia in critically ill patients?","volume":"177","author":"Thachil","year":"2017","journal-title":"Br. J. Haematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/bjh.16850","article-title":"COVID-19-associated immune thrombocytopenia","volume":"190","author":"Bomhof","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0037-1616880","article-title":"Thrombocytopenia during pregnancy. Importance, diagnosis and management","volume":"26","author":"Boehlen","year":"2006","journal-title":"Hamostaseologie"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/978-1-4615-3806-6_38","article-title":"Thrombotic microangiopathy","volume":"281","author":"Kwaan","year":"1990","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/j.molimm.2010.05.009","article-title":"Complement activation on platelets: Implications for vascular inflammation and thrombosis","volume":"47","author":"Peerschke","year":"2010","journal-title":"Mol. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/cei.13475","article-title":"Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course","volume":"201","author":"Castelli","year":"2020","journal-title":"Clin. Exp. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1182\/bloodadvances.2021004957","article-title":"Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination","volume":"5","author":"Portuguese","year":"2021","journal-title":"Blood Adv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1182\/blood.V120.21.1096.1096","article-title":"Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)","volume":"120","author":"Godfrey","year":"2012","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually Large Plasma Factor VIII: Von Willebrand Factor Multimers in Chronic Relapsing Thrombotic Thrombocytopenic Purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.imbio.2016.10.014","article-title":"Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies","volume":"222","author":"Farkas","year":"2017","journal-title":"Immunobiology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jhep.2016.06.002","article-title":"von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia","volume":"65","author":"Kalambokis","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/BF00320876","article-title":"Increased factor VIII\/vWf levels in patients with reduced platelet number","volume":"54","author":"Casonato","year":"1987","journal-title":"Blut"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1182\/bloodadvances.2017007989","article-title":"ITP and thrombosis: An intriguing association","volume":"1","author":"Rodeghiero","year":"2017","journal-title":"Blood Adv."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.17390","article-title":"Thrombosis in immune thrombocytopenia\u2014Current status and future per-spectives","volume":"194","author":"Swan","year":"2021","journal-title":"Br. J. Haematol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13045-020-01003-z","article-title":"Thrombocytopenia and thrombosis in hospitalized patients with COVID-19","volume":"13","author":"Mei","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/00365513.2014.962597","article-title":"Thrombophilia in patients with chronic immune thrombocytopenia","volume":"75","author":"Wong","year":"2015","journal-title":"Scand. J. Clin. Lab. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of Plasma Exchange with Plasma Infusion in the Treatment of Thrombotic Thrombocytopenic Purpura","volume":"325","author":"Rock","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1046\/j.1537-2995.1984.24585017826.x","article-title":"Intensive plasma exchange therapy in ten patients with idiopathic thrombocytopenic purpura","volume":"24","author":"Blanchette","year":"1984","journal-title":"Transfusion"},{"key":"ref_59","first-page":"133","article-title":"Mechanisms of IVIG action in immune thrombocytopenic purpura","volume":"50","author":"Hansen","year":"2004","journal-title":"Clin. Lab."},{"key":"ref_60","first-page":"374","article-title":"Traitement des microangiopathies thrombotiques [Treatment of thrombotic microangiopathies]","volume":"150","author":"Debourdeau","year":"1999","journal-title":"Ann. Med. Interne"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0272-6386(12)80888-2","article-title":"Should Intravenous Immunoglobulin G Be First-Line Treatment for Acute Thrombotic Thrombocytopenic Purpura? Case Report and Review of the Literature","volume":"18","author":"Raniele","year":"1991","journal-title":"Am. J. Kidney Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3324\/haematol.2019.218883","article-title":"Rituximab in the treatment of immune thrombocytopenia: What is the role of this agent in 2019?","volume":"104","author":"Lucchini","year":"2019","journal-title":"Haematologica"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jca.20091","article-title":"Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine\/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders","volume":"21","author":"George","year":"2006","journal-title":"J. Clin. Apher."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1177\/0300060517695646","article-title":"Rituximab as first-line treatment for acquired thrombotic thrombocytopenic purpura","volume":"45","author":"Chen","year":"2017","journal-title":"J. Int. Med. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine Storm","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_66","first-page":"51","article-title":"Multi-system inflammatory syndrome in children & adolescents (MIS-C): A sys-tematic review of clinical features and presentation","volume":"38","author":"Radia","year":"2021","journal-title":"Paediatr. Respir. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1016\/j.vaccine.2021.01.054","article-title":"Multisystem inflammatory syndrome in children and adults (MIS-C\/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data","volume":"39","author":"Vogel","year":"2021","journal-title":"Vaccine"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","article-title":"Multisystem inflammatory syndrome in children and Kawasaki disease: A critical comparison","volume":"17","author":"Sharma","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11926-005-0039-2","article-title":"Polyarteritis nodosa revisited","volume":"7","author":"Colmegna","year":"2005","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/TA.0b013e318232a6b3","article-title":"Necrotizing fasciitis: Classification, diagnosis, and management","volume":"72","author":"Lancerotto","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1056\/NEJM200009213431207","article-title":"Thromboangiitis obliterans (Buerger\u2019s disease)","volume":"343","author":"Olin","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1096\/fasebj.6.8.1592209","article-title":"Cytokine Regulation of Endothelial Cell Function","volume":"6","author":"Mantovani","year":"1992","journal-title":"FASEB J."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Turner, N.A., and Moake, J.L. (2015). Factor VIII Is Synthesized in Human Endothelial Cells, Packaged in Weibel-Palade Bodies and Secreted Bound to ULVWF Strings. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0140740"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/hrt.2007.135277","article-title":"Endothelial dysfunction and pathophysiological correlates in atrial fibrillation","volume":"95","author":"Guazzi","year":"2009","journal-title":"Heart"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1309\/AJCP66QIMFARLZKI","article-title":"Degos disease: A C5b-9\/interferon-\u03b1-mediated endotheliopathy syndrome","volume":"135","author":"Magro","year":"2011","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s00467-002-0885-3","article-title":"Endothelin levels in Henoch-Schonlein purpura","volume":"17","author":"Muslu","year":"2002","journal-title":"Pediatr. Nephrol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.12998\/wjcc.v9.i25.7319","article-title":"Aortic stenosis and Heyde\u2019s syndrome: A comprehensive review","volume":"9","author":"Lourdusamy","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0165-0173(00)00043-6","article-title":"Evidence that Alzheimer\u2019s disease is a microvascular disorder: The role of constitutive nitric oxide","volume":"34","author":"Stefano","year":"2000","journal-title":"Brain Res. Brain Res. Rev."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1073\/pnas.86.20.8152","article-title":"Hypothesis: Microtubules, a key to Alzheimer disease","volume":"86","author":"Matsuyama","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<11::AID-AJH3>3.0.CO;2-8","article-title":"Postoperative thrombotic thrombocytopenic purpura following cardiovascular surgeries","volume":"53","author":"Chang","year":"1996","journal-title":"Am. J. Hematol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.athoracsur.2009.09.019","article-title":"Postoperative Thrombotic Thrombocytopenic Purpura after Open Heart Operations","volume":"89","author":"Saltzman","year":"2010","journal-title":"Ann. Thorac. Surg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1368-5031.2004.0080.x","article-title":"Post-operative thrombotic thrombocytopenic purpura: A review","volume":"58","author":"Naqvi","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41409-021-01283-0","article-title":"Transplant-associated thrombotic microangiopathy: Theoretical considerations and a practical approach to an unrefined diagnosis","volume":"56","author":"Young","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"ref_84","first-page":"273","article-title":"Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases","volume":"61","author":"Bijl","year":"2003","journal-title":"Neth. J. Med."},{"key":"ref_85","first-page":"e2021110","article-title":"Atypical Reye syndrome: Three cases of a problem that pediatricians should consider and remember","volume":"92","author":"Ferretti","year":"2021","journal-title":"Acta Bio-Med. Atenei Parm."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.tmrv.2020.08.002","article-title":"Evaluation of Platelet Responses in Transfusion-Related Acute Lung Injury (TRALI)","volume":"34","author":"Porcelijn","year":"2020","journal-title":"Transf. Med. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1977.03280050048019","article-title":"Thrombotic Thrombocytopenic Purpura-like Syndrome Associated with Infective Endocarditis","volume":"238","author":"Bayer","year":"1977","journal-title":"JAMA"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/j.bbmt.2012.10.023","article-title":"Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Novel Insights to Pathogenesis, Current Status of Treatment, and Future Directions","volume":"19","author":"Richardson","year":"2013","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","article-title":"Microthrombi as a Major Cause of Cardiac Injury in COVID-19: A Pathologic Study","volume":"143","author":"Pellegrini","year":"2021","journal-title":"Circulation"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/br.2017.945","article-title":"Decreased activity of plasma ADAMTS13 are related to enhanced cytokinemia and endotoxemia in patients with acute liver failure","volume":"7","author":"Takaya","year":"2017","journal-title":"Biomed. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"484903","DOI":"10.1155\/2013\/484903","article-title":"Hepatic Manifestations in Hematological Disorders","volume":"2013","author":"Murakami","year":"2013","journal-title":"Int. J. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ejim.2009.09.008","article-title":"Lessons from acute pancreatitis-induced thrombotic thrombocytopenic purpura","volume":"20","author":"Thachil","year":"2009","journal-title":"Eur. J. Intern. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jcp.2003.9936","article-title":"Waterhouse-Friderichsen syndrome as a result of non-meningococcal infection","volume":"57","author":"Hamilton","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1093\/ndt\/gfq437","article-title":"Thrombotic thrombocytopenic purpura associated with anti-glomerular basement membrane disease","volume":"25","author":"Torok","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s11255-012-0279-9","article-title":"Goodpasture\u2019s syndrome associated with thrombotic thrombocytopenic purpura secondary to an ADAMTS-13 deficit","volume":"45","author":"Bajo","year":"2013","journal-title":"Int. Urol. Nephrol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2147\/IJGM.S20815","article-title":"Acute renal failure and severe rhabdomyolysis in a patient with resistant thrombotic thrombocytopenic purpura","volume":"4","author":"Qahtani","year":"2011","journal-title":"Int. J. Gen. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"e237616","DOI":"10.1136\/bcr-2020-237616","article-title":"Rhabdomyolysis and acute kidney injury in severe COVID-19 infection","volume":"13","author":"Taxbro","year":"2020","journal-title":"BMJ Case Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"758313","DOI":"10.3389\/fphys.2021.758313","article-title":"Microtubules as Major Regulators of Endothelial Function: Implication for Lung Injury","volume":"12","author":"Karki","year":"2021","journal-title":"Front. Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1309\/LM72AM5XFHZYOQCB","article-title":"Scleroderma Renal Crisis or Thrombotic Thrombocytopenic Purpura: Seeing Through the Masquerade","volume":"46","author":"Keeler","year":"2015","journal-title":"Lab. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.semarthrit.2004.08.008","article-title":"Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis","volume":"34","author":"Manadan","year":"2005","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.gene.2018.05.041","article-title":"The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry","volume":"668","author":"Goulielmos","year":"2018","journal-title":"Gene"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5694\/mja2.50262","article-title":"Antiphospholipid syndrome: A clinical review","volume":"211","author":"Mezhov","year":"2019","journal-title":"Med. J. Aust."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2009.12.004","article-title":"Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin","volume":"9","author":"Galeotti","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): Can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tmrv.2017.10.001","article-title":"Purpura Fulminans: Mechanism and Management of Dysregulated Hemostasis","volume":"32","author":"Colling","year":"2018","journal-title":"Transfus. Med. Rev."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.beha.2008.02.003","article-title":"Vascular endothelium and graft-versus-host disease","volume":"21","author":"Biedermann","year":"2008","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4065\/78.4.421","article-title":"Posttransplantation Thrombotic Thrombocytopenic Purpura: A Single-Center Experience and a Contemporary Review","volume":"78","author":"Elliott","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"ref_108","first-page":"123","article-title":"A Review of Raynaud\u2019s Disease","volume":"113","author":"Temprano","year":"2016","journal-title":"Mo. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.intimp.2015.07.044","article-title":"Inflammation in venous thromboembolism: Cause or consequence?","volume":"28","author":"Saghazadeh","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Favaloro, E.J., Pasalic, L., and Lippi, G. (2022). Antibodies against Platelet Factor 4 and Their Associated Pathologies: From HIT\/HITT to Spontaneous HIT-Like Syndrome, to COVID-19, to VITT\/TTS. Antibodies, 11.","DOI":"10.3390\/antib11010007"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMe2106315","article-title":"SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia","volume":"384","author":"Cines","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/09537104.2017.1366973","article-title":"Spontaneous HIT syndrome post-knee replacement surgery with delayed recovery of thrombocytopenia: A case report and literature review","volume":"28","author":"Poudel","year":"2017","journal-title":"Platelets"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3892\/ijmm.2020.4659","article-title":"Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review)","volume":"46","author":"Cavalli","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1177\/09612033211062523","article-title":"COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION)","volume":"30","author":"Wang","year":"2021","journal-title":"Lupus"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1056\/NEJMc2111305","article-title":"No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination","volume":"385","author":"Uzun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/jth.13066","article-title":"Distinguishing between anti-platelet factor 4\/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia","volume":"13","author":"Nazi","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Terpos, E., Politou, M., Ntanasis-Stathopoulos, I., Karalis, V., Merkouri, E., Fotiou, D., Gavriatopoulou, M., Malandrakis, P., Kastritis, E., and Trougakos, I. (2021). High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events. Vaccines, 9.","DOI":"10.3390\/vaccines9070712"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1515\/cclm-2021-0623","article-title":"The high frequency of anti-PF4\/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis","volume":"59","author":"Pascreau","year":"2021","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1160\/TH16-06-0435","article-title":"Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia","volume":"116","author":"Warkentin","year":"2016","journal-title":"Thromb. Haemost."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s10067-021-05724-5","article-title":"Are antiphospholipid antibodies just a common epi-phenomenon or are they causative of immune-mediated coagulopathy in COVID-19?","volume":"40","author":"Torres","year":"2021","journal-title":"Clin. Rheumatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1161\/CIRCULATIONAHA.114.008298","article-title":"Degradation of platelet-von Willebrand factor complexes by plasmin: An alternative\/backup mechanism to ADAMTS13","volume":"129","author":"Chauhan","year":"2014","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1074\/jbc.M116.760660","article-title":"Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation","volume":"292","author":"Lord","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.molmed.2016.07.002","article-title":"Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases","volume":"22","author":"Opdenakker","year":"2016","journal-title":"Trends Mol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12016-014-8424-0","article-title":"The Clinical Significance of Posttranslational Modification of Autoantigens","volume":"47","author":"Bugarin","year":"2014","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.4049\/jimmunol.170.12.6151","article-title":"The Autoreactivity of Anti-Phosphorylcholine Antibodies for Atherosclerosis-Associated Neo-Antigens and Apoptotic Cells","volume":"170","author":"Shaw","year":"2003","journal-title":"J. Immunol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/rheumatology\/ken014","article-title":"Consequence of neo-antigenicity of the \u2018altered self\u2019","volume":"47","author":"Eggleton","year":"2008","journal-title":"Rheumatology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1097\/00002030-199907090-00024","article-title":"Antiphospholipid antibodies are an epiphenomenon in HIV-infected patients","volume":"13","author":"Ankri","year":"1999","journal-title":"AIDS"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/mds.870120518","article-title":"Antiphospholipid antibodies: An epiphenomenon in tourette syndrome","volume":"12","author":"Singer","year":"1997","journal-title":"Mov. Disord."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0049-3848(99)00057-2","article-title":"Antiplatelet Factor 4\u2014Heparin Antibodies in Patients with Antiphospholipid Antibodies","volume":"95","author":"Martinuzzo","year":"1999","journal-title":"Thromb. Res."},{"key":"ref_130","first-page":"403","article-title":"White clot syndrome associated with heparin-induced thrombocytopenia: A review of 23 cases","volume":"16","author":"Chang","year":"1987","journal-title":"Heart Lung"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/01.CIR.0000066696.57519.AF","article-title":"Anti-platelet factor 4\/heparin antibodies: An independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes","volume":"107","author":"Williams","year":"2003","journal-title":"Circulation"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/9\/1311\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:34:21Z","timestamp":1760142861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/9\/1311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":131,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["medicina58091311"],"URL":"https:\/\/doi.org\/10.3390\/medicina58091311","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]}}}